Air Purifier Company Seeks Emergency Fda Approval For Device That Rids Indoor Air Of Virus

---

Last week, Dallas-based ActivePure filed an application with the Food and Drug Administration seeking approval to use its range of plug-in air purifiers against SARS-CoV-2, the virus that causes covid-19. The devices are used in homes throughout the United States, utilizing technology shown in studies to kill airborne viruses within enclosed spaces.

Over the summer, the company’s Aerus Medical Guardian was designated a medical device by the FDA for use in health-care settings. At the time, it was shown to kill 99.98 percent of the live virus on surfaces within seven hours. Now, after further testing, the company says more of its products are effective against the virus. But this time it’s tackling the air.

Recent lab tests revealed ActivePure’s patented technology can kill airborne virus particles in three minutes, the company says. When turned on, its Aerus Pure and Clean and Vollara Air and Surface Pro devices work continuously to reduce pathogens indoors, even when people are present in the room.

“We are seeking the (emergency use authorization) for use in all indoor environments so that these areas will be safer for people all over the world in this time of pandemic and beyond,” said Joe Urso, CEO and chairman of ActivePure.

By Dalvin Brown
12-11-2020
Source and complete article: msn.com